Monitoring death and cancer in children born to HIV-infected women in England and Wales: Use of HIV surveillance and national routine data

AIDS

Volumn 21, Issue 7, 2007, Pages 867-869

  Hankin, Claire ^a   Lyall, Hermione ^b   Peckham, Catherine ^a   Tookey, Pat ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CANCER; CANCER RISK; DEATH; ETHICS; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONITORING; NATIONAL HEALTH SERVICE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; STATISTICS; TIME SERIES ANALYSIS; UNITED KINGDOM;

ANTI-HIV AGENTS; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; ENGLAND; FEMALE; HIV INFECTIONS; HUMANS; MATERNAL-FETAL EXCHANGE; MEDICAL RECORD LINKAGE; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; WALES;

EID: 34147160292     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280b01822     Document Type: Article

References (13)

1. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-465.
2. European Collaborative Study. Increased risk of adverse pregnancy outcomes in HAART-treated HIV infected women in Europe. AIDS 2004; 18:2337-2339.
3. Townsend CL, Tookey PA, Cortina-Borja M, Peckham CS. Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003. J Acquir Immune Defic Syndr 2006; 42:91-94.
4. Antiretroviral Pregnancy Registry International Interim Report. Available at: http://www.apregistry.com. Accessed: 26 July 2006.
5. Culnane M, Fowler MG, Lee SS, McSherry G, Brady M, O'Donnell K, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. JAMA 1999; 281:151-157.
6. Brogly S, Williams P, Seage GR III, Van Dyke R. In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the Pediatric AIDS Clinical Trials Group 219 and 219C cohorts. J Acquir Immune Defic Syndr 2006; 41:535-536.
7. Olivero OA, Anderson LM, Diwan BA, Haines DC, Harbaugh SW, Moskal TJ, et al. Transplacental effects of 3′-azido-2′, 3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst 1997; 89:1602-1608.
8. Hawkins D, Blott M, Clayden P, de Ruiter A, Foster G, Gilling-Smith C, et al. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med 2005; 6 (Suppl. 2):107-148.
9. Greenberg M, Coleman MP. Medical research at the Office for National Statistics: a review. Available at: http://www.statistics.gov.uk/downloads/ theme_health/SMPS65book.pdf. Accessed 19 March 2006.
10. Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002; 360:273-277.
11. Nevin NC, Spink J. Gene Therapy Advisory Committee long term monitoring of patients participating in gene therapy. Hum Gene Ther 2000; 11:1253-1255.
12. Office for National Statistics. Cancer statistics. Available at: http://www.statistics.gov.uk/downloads/theme_health/MB1_34/MB1_34.pdf. Accessed: 28 November 2006.
13. Connecting for Health. National programme for IT. Available at: http://www.connectingforhealth.nhs.uk. Accessed: 28 November 2006.